MSLE Satellos Bioscience Inc. - Common Stock
$9.81
Price · Aug 18, 2026
52W Range
$5–$13
58% of range
Analyst Rating
BUY
11 analysts
Price Target
$28
+182% upside
P/E (TTM)
—
ROE
—
Net Profit Margin
—
MSLE Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$9.81
Market Cap
—
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
—
Div Yield
—
ROE
—
Debt/Equity
—
52W Range
$5 – $13
MSLE Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
—
EPS
—
Free Cash Flow
—
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
MSLE
Peer Median
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
MSLE
Peer Median
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
MSLE
Peer Median
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
MSLE
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
MSLE
Peer Median
MSLE Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
BUY
11 analysts
- Strong Buy 4 36.4%
- Buy 6 54.5%
- Hold 1 9.1%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
3 analysts · 2026-08-17
Median
$23.00
Mean
$27.67
← Below all targets
$9.81
Low
$20.00
High
$40.00
Median target
$23.00
+134.5%
Mean target
$27.67
+182.0%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-0.25%
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| March 31, 2026 | $-0.53 | $-0.45 | -0.08% |
| Dec. 31, 2025 | $-1.60 | $-0.16 | -1.4% |
| Sept. 30, 2025 | $-0.36 | $-0.35 | -0.01% |
| June 30, 2025 | $-0.36 | $-0.43 | 0.06% |
| March 31, 2025 | $-0.48 | $-0.61 | 0.13% |
| Dec. 31, 2024 | $-0.65 | $-0.50 | -0.15% |
Peer comparison (GICS sub-industry) Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| MSLE | — | — | — | — | — | — |
| ABUS | $926M | -28.3 | 128.2% | -237.9% | -42.0% | — |
| ZYME | $1.97B | -24.4 | 38.9% | -76.6% | -26.9% | — |
| ACOG | $141M | -5.5 | — | -202.2% | -43.8% | — |
| PMN | $15M | -0.3 | — | — | 4840.3% | — |
| XENE | $3.59B | -10.3 | — | -4612.1% | -56.9% | — |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F) 26 filers · $59.4M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 2 | 7 | 5 | 7 | — |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair. Change vs prior quarter not shown: filer coverage differs too much between these two quarters for a reliable comparison.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| FRANKLIN RESOURCES INC | $7,227,934 | 938,666 | 12.16% | Shares |
| Siren, L.L.C. | $6,935,875 | 892,074 | 11.67% | Shares |
| Vivo Capital, LLC | $6,326,253 | 813,666 | 10.64% | Shares |
| Point72 Asset Management, L.P. | $5,307,993 | 682,700 | 8.93% | Shares |
| SPHERA FUNDS MANAGEMENT LTD. | $5,073,887 | 652,590 | 8.53% | Shares |
| Woodline Partners LP | $3,890,859 | 500,432 | 6.54% | Shares |
| Stonepine Capital Management, LLC | $3,723,291 | 491,624 | 6.26% | Shares |
| MONTANOVA CAPITAL, LLC | $3,693,125 | 475,000 | 6.21% | Shares |
| Avidity Partners Management LP | $3,014,904 | 387,769 | 5.07% | Shares |
| Saturn V Capital Management LP | $2,721,250 | 350,000 | 4.58% | Shares |
| Soleus Capital Management, L.P. | $2,444,141 | 314,359 | 4.11% | Shares |
| 683 Capital Management, LLC | $1,794,727 | 230,833 | 3.02% | Shares |
| ADAR1 Capital Management, LLC | $1,731,478 | 222,555 | 2.91% | Shares |
| AWM Investment Company, Inc. | $1,399,500 | 180,000 | 2.35% | Shares |
| MILLENNIUM MANAGEMENT LLC | $1,187,771 | 152,768 | 2.00% | Shares |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $1,166,250 | 150,000 | 1.96% | Shares |
| Empery Asset Management, LP | $832,703 | 107,100 | 1.40% | Shares |
| CITADEL ADVISORS LLC | $526,663 | 67,738 | 0.89% | Shares |
| MORGAN STANLEY | $197,353 | 25,383 | 0.33% | Shares |
| China Universal Asset Management Co., Ltd. | $155,500 | 20,000 | 0.26% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $92,576 | 11,907 | 0.16% | Shares |
| JPMORGAN CHASE & CO | $2,485 | 315 | 0.00% | Shares |
| ROYAL BANK OF CANADA | $2,000 | 200 | 0.00% | Shares |
| Federation des caisses Desjardins du Quebec | $143 | 19 | 0.00% | Shares |
| UBS Group AG | $8 | 1 | 0.00% | Shares |
| Caitong International Asset Management Co., Ltd | $8 | 1 | 0.00% | Shares |